The pharmaceutical landscape in Vietnam has undergone a radical transformation over the last decade. As one of the fastest-growing economies in Southeast Asia, Vietnam is positioning itself as a hub for Cardiovascular Health Drugs Factory & Exporters. With the Vietnamese government's Decision 376/QD-TTg, which aims to boost the domestic pharmaceutical industry, there is an unprecedented focus on high-tech drug production.
Cardiovascular diseases (CVDs) remain the leading cause of mortality in Vietnam, accounting for approximately 31% of all deaths. This health challenge has catalyzed the development of local manufacturing facilities that adhere to GMP-WHO standards. Factories in industrial zones such as Binh Duong, Dong Nai, and Bac Ninh are now integrating AI-driven quality control systems to ensure that medications—ranging from antihypertensives to advanced embolic microspheres—meet international export criteria.
GMP Factories
Annual Growth
Modern pharmaceutical manufacturing in Vietnam is no longer just about mass production; it is about precision. The integration of Artificial Intelligence (AI) and Internet of Things (IoT) in cardiovascular drug synthesis allows for real-time monitoring of chemical reactions. For instance, in the production of Magnesium and Anthocyanin supplements, AI algorithms optimize the extraction process to ensure maximum bioavailability.
Moreover, the use of Drug-Eluting Microspheres—a technology we specialize in—represents the cutting edge of cardiovascular and interventional oncology. These microspheres are designed for targeted delivery, reducing systemic side effects and improving patient outcomes in Vietnam’s leading cardiovascular centers like the Vietnam National Heart Institute. Our export operations utilize blockchain-based tracking to ensure that every batch of cardiovascular health drugs reaching the global market is authenticated and temperature-controlled.
Xian QLU Health Pharmaceutical Technology Co., Ltd. is a leader in the development, production, and marketing of pharmaceutical products, food ingredients, vitamins, and chemical intermediates. With a strategic focus on the Vietnam and Southeast Asian markets, we provide specialized solutions for cardiovascular health.
Headquartered in Xian, China, our 3 production bases in Shandong, Zhejiang, and Hebei boast years of expertise in APIs and vitamins. These facilities are certified by GMP, ISO, FAMI-QS, KOSHER, and HALAL. Our "Company Spirit" is defined by flexibility and adaptability—we embrace emerging technologies to meet the evolving needs of healthcare providers in Vietnam and beyond.
In Vietnam, cardiovascular health isn't just a clinical issue; it’s a lifestyle priority. Our Magnesium Tablets for Muscle Relaxation and Anthocyanin Softgels are tailored for the Vietnamese market where preventive medicine is gaining popularity. In urban centers like Ho Chi Minh City and Hanoi, the aging population increasingly relies on high-quality supplements to maintain heart rhythm and vascular elasticity.
For the Vietnam livestock industry, our Calcium Gluconate and Vitamin B12 solutions serve a critical role. Large-scale poultry and livestock farms in the Mekong Delta require consistent pharmaceutical-grade additives to ensure the health of their herds, which indirectly supports the nutritional chain and heart health of the Vietnamese populace.
Looking forward, the Cardiovascular Health Drugs Factory & Exporters in Vietnam are set to benefit from the EU-Vietnam Free Trade Agreement (EVFTA). This trade pact reduces tariffs and streamlines regulatory hurdles, making Vietnamese-produced pharmaceutical ingredients more competitive in the European and Global markets. QLU Health is at the forefront of this shift, utilizing our Mumbai and Dubai strategic marketing partners to bridge the gap between Asian manufacturing excellence and global demand.
The "Next-Gen" of heart health in Vietnam involves personalized medicine. We are exploring the development of smart-release magnesium formulations and customized antioxidant blends that cater to specific genetic markers prevalent in the Southeast Asian population. Our commitment to R&D and AI-enhanced manufacturing ensures that we remain a primary choice for distributors looking for reliable Vietnam cardiovascular drug exporters. Whether it is APIs for hospital use or retail-ready softgels, our supply chain is optimized for speed, safety, and scientific integrity.
Heart Health Focus
Certified Quality
Tech-Driven Mfg
QLU Health
